Key Points * Lack of transparency and competitiveness in procurement processes * Financial losses due to coal purchases above international market prices * Weak contract management and oversight * ...

The government’s defeat of the no-confidence motion against Minister of Energy Kumara Jayakody, by a large parliamentary majority, was not surprising. The vote was 153 against and 49 in favour – a ...

In an advance for precision oncology, the largest published study to date on molecular residual disease (MRD) detection in stage 3 colon cancer has demonstrated the prognostic capabilities of Guardant ...

Current clinical guidelines, including those of the European Association of Urology (EAU), consider a prior NMIBC tumor as a marker for increased risk of future recurrence and progression to ...

Extended endocrine therapy was associated with a 9% improvement in invasive breast cancer-free survival among premenopausal women with node-positive, HR-positive early disease. Extended endocrine ...

LinkedIn's algorithm has changed, making old tactics obsolete. Align your profile with content topics. Prioritize "saves" as the key engagement metric by creating valuable, referenceable content. Post ...

Switching to a different biologic therapy postoperatively may help individuals with CD have improved endoscopic outcomes. Patients with Crohn disease (CD) who use biologic therapies prior to ...

A tumor-informed ctDNA assay identified MRD in TNBC patients, indicating a 30-fold higher risk of distant recurrence for MRD-positive individuals. The NSABP B-59/GBG 96-GeparDouze trial involved 1550 ...

LONDON, Dec 10 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared with standard endocrine ...

At the heart of the deal is Relation’s Lab-in-the-Loop platform, which uses AI models to improve understanding of diseases and guide clinical development programs. Months after securing an approval ...

Impaired distal blood flow is a strong predictor of early recurrent stroke in symptomatic intracranial atherosclerosis, even with optimal medical therapy. Patients with symptomatic intracranial ...

At 3 months post-intervention, the researchers found that total Fear of Cancer Recurrence Inventory scores were reduced by a mean of 21.7 points for participants in the TG-iConquerFear group.